enhanc percutan absorpt novel topic cyclosporin formul assess immunosuppress activ success topic cyclosporin cya formul due appar lack drug penetr studi first vitro kinet data cya penetr human cadav stratum corneum addit penetr enhanc PE azon propylen glycol cya vehicl drug permeat skin barrier flow-through permeabl cell w/v cya sandimmun cya PE cya PE oliv oil donor chamber penetr rate mean SD receptor fluid cya cya PE vivo efficaci formul guinea-pig undergo delayed-typ hypersensit dth reaction dnfb cya time challeng daili skin reaction appropri drug vehicl concentr cya PE signific inhibitori effect erythema respons signific reduct t-cell infiltr cya signific reduct erythema cya PE reduct number lymphocyt site cya PE vehicle-tr site PE penetr non-immunosuppress concentr cya skin 